Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2089-2096

  Law, Alice Y S ^a   Yeung, B H Y ^a   Ching, L Y ^a   Wong, Chris K C ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Apoptosis; Chip; Immunoprecipitation; Luciferase reporter

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOCALCIN; LUCIFERASE; MITHRAMYCIN A; OKADAIC ACID; RETINOBLASTOMA PROTEIN; STANNIOCALCIN 1; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL POPULATION; CELL STRAIN HT29; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; HYDROXAMIC ACIDS; OKADAIC ACID; PHOSPHORYLATION; PLICAMYCIN; PROTEIN SYNTHESIS INHIBITORS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 79960376952     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23127     Document Type: Article

References (61)

1. Albertini V, Jain A, Vignati S, Napoli S, Rinaldi A, Kwee I, Nur-e-Alam M, Bergant J, Bertoni F, Carbone GM, Rohr J, Catapano CV,. 2006. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: Implications for cancer therapy. Nucleic Acids Res 34: 1721-1734.
2. Armstrong SA, Barry DA, Leggett RW, Mueller CR,. 1997. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem 272: 13489-13495. (Pubitemid 27224776)
3. Black AR, Black JD, Azizkhan-Clifford J,. 2001. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160. (Pubitemid 32622905)
4. Blaker H, Graf M, Rieker RJ, Otto HF,. 1999. Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases. J Pathol 188: 258-262. (Pubitemid 29317767)
5. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, Dimattia G, Sullivan DE, Prockop DJ,. 2009. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27: 670-681.
6. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ,. 2002. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62: 1289-1295. (Pubitemid 34407780)
7. Chang AC, Jeffrey KJ, Tokutake Y, Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y, Reddel RR,. 1998. Human stanniocalcin (STC): Genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats. Genomics 47: 393-398. (Pubitemid 28110652)
8. Chang YC, Illenye S, Heintz NH,. 2001. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. Mol Cell Biol 21: 1121-1131. (Pubitemid 32114961)
9. Chang AC, Jellinek DA, Reddel RR,. 2003. Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10: 359-373. (Pubitemid 37267555)
10. Chu S, Ferro TJ,. 2005. Sp1: Regulation of gene expression by phosphorylation. Gene 348: 1-11. (Pubitemid 40410011)
11. Chughtai SA, Crundwell MC, Cruickshank NR, Affie E, Armstrong S, Knowles MA, Takle LA, Kuo M, Khan N, Phillips SM, Neoptolemos JP, Morton DG,. 1999. Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer. Oncogene 18: 657-665. (Pubitemid 29080323)
12. Chun RF, Semmes OJ, Neuveut C, Jeang KT,. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J Virol 72: 2615-2629. (Pubitemid 28175495)
13. Daniel AR, Lange CA,. 2009. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc Natl Acad Sci USA 106: 14287-14292.
14. Daniel S, Zhang S, DePaoli-Roach AA, Kim KH,. 1996. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J Biol Chem 271: 14692-14697. (Pubitemid 26194944)
15. De Niu P, Radman DP, Jaworski EM, Deol H, Gentz R, Su J, Olsen HS, Wagner GF,. 2000. Development of a human stanniocalcin radioimmunoassay: Serum and tissue hormone levels and pharmacokinetics in the rat. Mol Cell Endocrinol 162: 131-144. (Pubitemid 30347456)
16. Deniaud E, Baguet J, Mathieu AL, Pages G, Marvel J, Leverrier Y,. 2006. Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25: 7096-7105. (Pubitemid 44722077)
17. Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, Meunier J, Michallet MC, Laugraud A, Ah-Soon C, Wierinckx A, Castellazzi M, Lachuer J, Gautier C, Marvel J, Leverrier Y,. 2009. Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS ONE 4: e7035.
18. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA,. 2006. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45: 31-41. (Pubitemid 46930859)
19. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C,. 1999. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19: 5504-5511. (Pubitemid 29339908)
20. Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS, Elkahloun AG,. 2004. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: Activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer 11: 897-911. (Pubitemid 40065561)
21. Fojas dB, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M,. 2001. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J 20: 5737-5747. (Pubitemid 33010050)
22. Gerritsen ME, Wagner GF,. 2005. Stanniocalcin: No longer just a fish tale. Vitam Horm 70: 105-135. (Pubitemid 43631306)
23. Holmes DI, Zachary IC,. 2008. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. Cell Signal 20: 569-579.
24. Ishibashi K, Imai M,. 2002. Prospect of a stanniocalcin endocrine/paracrine system in mammals. Am J Physiol Renal Physiol 282: F367-F375. (Pubitemid 34654525)
25. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Jr., Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO,. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87. (Pubitemid 29044852)
26. Joensuu K, Heikkila P, Andersson LC,. 2008. Tumor dormancy: Elevated expression of stanniocalcins in late relapsing breast cancer. Cancer Lett 265: 76-83.
27. Johnson DG, Schneider-Broussard R,. 1998. Role of E2F in cell cycle control and cancer. Front Biosci 3: d447-d448.
28. Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, Vehar G, Schoenfeld J, Grimaldi CJ, Peale F, Draksharapu A, Lewin DA, Gerritsen ME,. 2000. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 156: 1887-1900. (Pubitemid 30641758)
29. Klein D, Demory A, Peyre F, Kroll J, Geraud C, Ohnesorge N, Schledzewski K, Arnold B, Goerdt S,. 2009. Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1. Angiogenesis 12: 251-265.
30. Klopfleisch R, Gruber AD,. 2009. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. J Comp Pathol 141: 113-120.
31. Knosel T, Schluns K, Stein U, Schwabe H, Schlag PM, Dietel M, Petersen I,. 2004. Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia 6: 23-28. (Pubitemid 38391946)
32. Koide Y, Sasaki T,. 2006. Stanniocalcin-1 (STC-1) as a molecular marker for human cancer. Rinsho Byori 54: 213-220.
33. Lacroix I, Lipcey C, Imbert J, Kahn-Perles B,. 2002. Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes. J Biol Chem 277: 9598-9605. (Pubitemid 34953049)
34. Lai KP, Law AY, Yeung HY, Lee LS, Wagner GF, Wong CK,. 2007. Induction of stanniocalcin-1 expression in apoptotic human nasopharyngeal cancer cells by p53. Biochem Biophys Res Commun 356: 968-975. (Pubitemid 46529385)
35. Law AY, Lai KP, Lui WC, Wan HT, Wong CK,. 2008. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Exp Cell Res 314: 2975-2984.
36. Law AY, Ching LY, Lai KP, Wong CK,. 2010. Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene. Mol Cell Endocrinol 314: 118-127.
37. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S,. 2008. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 8: 187.
38. McCudden CR, Majewski A, Chakrabarti S, Wagner GF,. 2004. Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas. Mol Cell Endocrinol 213: 167-172. (Pubitemid 38210048)
39. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F,. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763. (Pubitemid 38030303)
40. Milanini-Mongiat J, Pouyssegur J, Pages G,. 2002. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277: 20631-20639. (Pubitemid 34967366)
41. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DS,. 2007. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13: 4105-4110. (Pubitemid 47105972)
42. Nguyen A, Chang AC, Reddel RR,. 2009. Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene 28: 1982-1992.
43. Parniewski P, Staczek P,. 2002. Molecular mechanisms of TRS instability. Adv Exp Med Biol 516: 1-25. (Pubitemid 36337734)
44. Safe S, Abdelrahim M,. 2005. Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438-2448. (Pubitemid 41540621)
45. Samson SL, Wong NC,. 2002. Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol 29: 265-279. (Pubitemid 36024543)
46. Sanchez-Elsner T, Ramirez JR, Sanz-Rodriguez F, Varela E, Bernabeu C, Botella LM,. 2004. A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol 336: 9-24. (Pubitemid 38102327)
47. Sastry M, Patel DJ,. 1993. Solution structure of the mithramycin dimer-DNA complex. Biochemistry 32: 6588-6604. (Pubitemid 23217128)
48. Schafer D, Hamm-Kunzelmann B, Brand K,. 1997. Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1. FEBS Lett 417: 325-328. (Pubitemid 27511614)
49. Song Y, Wu J, Oyesanya RA, Lee Z, Mukherjee A, Fang X,. 2009. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. Clin Cancer Res 15: 492-501.
50. Tohmiya Y, Koide Y, Fujimaki S, Harigae H, Funato T, Kaku M, Ishii T, Munakata Y, Kameoka J, Sasaki T,. 2004. Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia. Tohoku J Exp Med 204: 125-133. (Pubitemid 39335051)
51. Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE,. 1998. Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139: 4714-4725. (Pubitemid 28487791)
52. Wagner GF, DiMattia GE,. 2006. The stanniocalcin family of proteins. J Exp Zoolog A Comp Exp Biol 305: 769-780. (Pubitemid 44358304)
53. Wary KK, Thakker GD, Humtsoe JO, Yang J,. 2003. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2: 25.
54. Westberg JA, Serlachius M, Lankila P, Andersson LC,. 2007a. Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart. Am J Physiol Heart Circ Physiol 293: H1766-1771. (Pubitemid 47367226)
55. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC,. 2007b. Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38: 1025-1030. (Pubitemid 46568469)
56. Wu S, Yoshiko Y, De Luca F,. 2006. Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. J Biol Chem 281: 5120-5127. (Pubitemid 43847777)
57. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CK,. 2005. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146: 4951-4960. (Pubitemid 41446634)
58. Yoshiko Y, Aubin JE,. 2004. Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides 25: 1663-1669. (Pubitemid 39346208)
59. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC,. 2000. Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA 97: 3637-3642. (Pubitemid 30183355)
60. Zhang Y, Liao M, Dufau ML,. 2006. Phosphatidylinositol 3-kinase/protein kinase czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Mol Cell Biol 26: 6748-6761. (Pubitemid 44387626)
61. Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV, Jr., Gerritsen ME,. 2003. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor. J Biol Chem 278: 47654-47659. (Pubitemid 37523210)